澳门新萄京9820

| | 学院内网| 化院信箱
Jianjun Li研究员学士报告(4月10日15:00,化西210)
来源: 作者: 更新时间:2019-04-08

报告题目:Mass spectrometry for cancer immunotherapy

报告人:Jianjun Li

Senior Research Officer and Team Lead of Bioanalysis at Human Health Therapeutics of National Research Council, Canada

时间:4月10日(周三),下午15:00

地点:化西210

报告人简介:

Dr. Jianjun Li is a Senior Research Officer and Team Lead of Bioanalysis at Human Health Therapeutics of National Research Council (NRC-HHT). He received his B. Sc. in Chemistry and Ph. D. in Analytical Chemistry from Wuhan University, in 1983 and 1993, respectively. Dr. Li’s research has involved the development of high-resolution separation techniques coupled with mass spectrometry and their applications to the structural characterization of various biologically molecules. From 1997 to 2001, he focused on the development of chip-based capillary electrophoresis-mass spectrometry systems. His current research interest is method development and application for bacterial vaccine and cancer vaccine, including the structure and biosynthesis of bacterial surface carbohydrates and cancer neoantigen presented by major histocompatibility complex (MHC). He is author or co-author of over 200 original peer-reviewed scientific papers, 8 book chapters and edits the book entitled Methods in Functional Glycomics.

地址:湖北省武汉市武昌区八一路299号 邮编:430072 鄂ICP备05003330    Copyright © 澳门新萄京9820  技术支持 思古科技